Komori
Shochiku (9601) · RiskRestated

Fluctuations in Theatrical Production Performance Due to Performers and Customer Preferences

First written in FY2017. 4 of 11 entries say "Restated". Latest entry: FY2026.

11entries
10years
0from disclosures
Share on X
How it moved
ProgressHeldSoftenedWorseFirst statedFY2017RestatedFY2022-Q1 – FY2022-Q2MaterialisedFY2023-Q2 – FY2024-Q2RestatedFY2024 – FY20262017: 120172018: 020182019: 020192020: 120202021: 320212022: 120222023: 320232024: 120242025: 020252026: 12026
Same theme, other companies

Shochiku moved to the "Worse" side of this theme in 2020, 4 years before the typical company in this theme (2024).

4 other companies' latest entry also says "Restated".

Ridges = years it wrote progress, valleys = years it wrote worse. Most hopeful companies at the back. Drag to turn, scroll to zoom, right-drag to pan. On a phone, two fingers turn and pinch to zoom; one finger scrolls the page.
Full recordFilings, disclosures and news, newest first
  1. FY2026RestatedAnnual report

    「The company also strives to provide attractive performances that consistently satisfy customers, but attendance may be significantly affected by the popularity and recognition of productions and performing actors, as well as changes in customer preferences.」

    The company continues to identify the risk of fluctuations in attendance due to the popularity of performers and productions and customer preferences.
  2. FY2024RestatedAnnual report

    「“Heike Nyogo no Shima: Onai no Matsu,” presented in January, Super Kabuki “Yamato Takeru,” presented in February, the June Atami Goro Ichiza production, for which some performances were canceled, and “Beetlejuice,” presented in August, among others, were also very well received.」

    While some performances were canceled, multiple productions were well received and performed strongly. Volatility in performance results due to performers and customer preferences continues.
  3. FY2024-Q2MaterialisedAnnual report

    「Some performances of the June Atami Goro Ichiza production and the August production of “Beetlejuice” were canceled, but both were very well received.」

    Some performances were actually canceled in the theater business. Despite the cancellations, the productions concerned were described as very well received.
  4. FY2023MaterialisedAnnual report

    「However, some performances were canceled as the number of infections increased from July to August with the spread of the Omicron variant.」

    Some performances were actually canceled during the year because of infections among stage personnel.
  5. FY2023-Q3MaterialisedAnnual report

    「However, some performances were canceled as the number of infections increased from July to August with the spread of the Omicron variant.」

    Some performances were actually canceled because of the infectious disease. The company also reported measures to continue performances, such as arranging understudies for absent performers.
  6. FY2023-Q2WorsenedAnnual report

    「The theater industry continued to respond to cases of COVID-19 among those involved in productions. During the period, the company continued to hold performances while thoroughly implementing infection-prevention measures, including restaging performances that had been canceled because of infections among stage personnel, in an effort to return conditions as much as possible to those before COVID-19.」

    The company reported that performances were actually canceled because of infections among stage personnel and other causes, and that it responded by restaging performances and implementing infection-prevention measures. The risk of fluctuations in performances and attendance due to the infectious disease continues.
  7. FY2022-Q2RestatedAnnual report

    「Although some performances in the theater industry had to be canceled or suspended, the company shared information closely with the Emergency Stage Arts Network, which comprises organizations involved in the performing arts, implemented thorough infection-prevention measures and held performances.」

    Performance cancellations and suspensions due to the infectious disease coexisted with performances held after infection-prevention measures were implemented, and conditions continued in which attendance and the ability to hold performances were affected by the infectious disease.
  8. FY2022-Q1RestatedAnnual report

    「To prevent the spread of COVID-19, theater productions at Shochiku's directly operated theaters continued to limit audience capacity, implement thorough infection-control measures and stage performances with due regard for audience safety and peace of mind. However, following the declaration of a state of emergency, some performances scheduled for April and May were canceled for part or all of their runs.」

    While continuing to hold performances with reduced capacity during the infectious disease outbreak, some performances were canceled for part or all of their scheduled periods because of the state of emergency.
  9. FY2021WorsenedAnnual report

    「After performances were canceled or suspended because of the infectious disease, the theater industry resumed performances while thoroughly implementing infection-prevention measures and making adjustments to schedules and running times. The challenge has been to continue producing performances suited to customer preferences, maintain attendance, and develop new sales channels such as video distribution.」

    In addition to the existing risk of fluctuations in attendance due to customer preferences, the company identified cancellations and performance suspensions caused by the infectious disease, maintaining attendance and developing new sales channels as challenges.
  10. FY2020WorsenedAnnual report

    「The theater industry continues to face a situation in which customers make highly selective choices among productions. The challenge has been to produce performances and projects that match customer preferences, maintain current audience numbers, and develop new sales channels.」

    The company explicitly identified as challenges the continuing selectivity of audiences, matching customer preferences, maintaining attendance and developing new sales channels.
  11. FY2017First statedAnnual report

    「Performers may become unable to appear because of health reasons, unforeseen accidents or other causes. Although the group has taken measures such as maintaining a situation in which understudies can always perform if necessary, this could affect the group’s operating performance and financial condition in some cases.」

    The company describes the risk that performers may be unable to appear because of health issues or accidents, together with maintaining understudies as a countermeasure. The same risk item also identifies fluctuations in attendance due to customer preferences and the popularity of productions and performers.
Moved together

"Revenue contribution from product sales and related services" moved the same way as this thread, in the same document, in 6 of its 11 moves.

64322★12345
  1. ★This thread
  2. 1Revenue contribution from product sales and related services6×
  3. 2Yen Appreciation, Falling Stock Prices and Uncertainty over the Economic Outlook4×
  4. 3Impairment Losses on Fixed Assets3×
  5. 4Disaster and Sanitation Issues at Facilities Accommodating Large Numbers of Customers2×
  6. 5Fluctuations in Leasing Earnings Due to Rising Vacancy Rates and the Departure of Major Tenants2×

★ is this thread; numbers match the list above. The number on a line is how many documents both moved the same way in; lines between the other threads count the documents they moved together in too. Threads that move together often sit closer.

When this could move next
No upcoming earnings preview for Shochiku yet.
News
No news is linked to this thread yet. When an article touches it, it will appear here by date.
Fluctuations in Theatrical Production Performance Due to Performers and Customer Preferences | Shochiku Co.,Ltd. (9601) | Komori